Annual Cash & Cash Equivalents:
$69.53M+$3.15M(+4.74%)Summary
- As of today, TNGX annual cash & cash equivalents is $69.53 million, with the most recent change of +$3.15 million (+4.74%) on December 31, 2024.
- During the last 3 years, TNGX annual cash & cash equivalents has fallen by -$73.22 million (-51.29%).
- TNGX annual cash & cash equivalents is now -51.29% below its all-time high of $142.75 million, reached on December 31, 2021.
Performance
TNGX Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$153.24M-$27.97M(-15.44%)Summary
- As of today, TNGX quarterly cash & cash equivalents is $153.24 million, with the most recent change of -$27.97 million (-15.44%) on September 30, 2025.
- Over the past year, TNGX quarterly cash & cash equivalents has dropped by -$140.04 million (-47.75%).
- TNGX quarterly cash & cash equivalents is now -69.58% below its all-time high of $503.81 million, reached on September 30, 2021.
Performance
TNGX Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TNGX Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +4.7% | -47.8% |
| 3Y3 Years | -51.3% | -61.1% |
| 5Y5 Years | +145.0% | +9772.4% |
TNGX Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -51.3% | +15.9% | -61.1% | at low |
| 5Y | 5-Year | -51.3% | +145.0% | -69.6% | >+9999.0% |
| All-Time | All-Time | -51.3% | +145.0% | -69.6% | >+9999.0% |
TNGX Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $153.24M(-15.4%) |
| Jun 2025 | - | $181.21M(-16.6%) |
| Mar 2025 | - | $217.15M(-15.8%) |
| Dec 2024 | $69.53M(+4.7%) | $257.92M(-12.1%) |
| Sep 2024 | - | $293.28M(-9.0%) |
| Jun 2024 | - | $322.11M(-6.3%) |
| Mar 2024 | - | $343.60M(+1.7%) |
| Dec 2023 | $66.39M(+10.7%) | $337.74M(-6.4%) |
| Sep 2023 | - | $360.74M(+15.8%) |
| Jun 2023 | - | $311.51M(-6.6%) |
| Mar 2023 | - | $333.64M(-9.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $59.97M(-58.0%) | $366.70M(-6.9%) |
| Sep 2022 | - | $393.86M(-5.5%) |
| Jun 2022 | - | $416.92M(-7.4%) |
| Mar 2022 | - | $450.45M(-7.3%) |
| Dec 2021 | $142.75M(+403.0%) | $485.82M(-3.6%) |
| Sep 2021 | - | $503.81M(>+9900.0%) |
| Jun 2021 | - | $582.90K(-53.7%) |
| Mar 2021 | - | $1.26M(-99.3%) |
| Dec 2020 | $28.38M | $190.32M(>+9900.0%) |
| Sep 2020 | - | $1.55M(+6108.8%) |
| Jun 2020 | - | $25.00K |
FAQ
- What is Tango Therapeutics, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Tango Therapeutics, Inc.?
- What is Tango Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
- What is Tango Therapeutics, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Tango Therapeutics, Inc.?
- What is Tango Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
What is Tango Therapeutics, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of TNGX is $69.53M
What is the all-time high annual cash & cash equivalents for Tango Therapeutics, Inc.?
Tango Therapeutics, Inc. all-time high annual cash & cash equivalents is $142.75M
What is Tango Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, TNGX annual cash & cash equivalents has changed by +$3.15M (+4.74%)
What is Tango Therapeutics, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of TNGX is $153.24M
What is the all-time high quarterly cash & cash equivalents for Tango Therapeutics, Inc.?
Tango Therapeutics, Inc. all-time high quarterly cash & cash equivalents is $503.81M
What is Tango Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, TNGX quarterly cash & cash equivalents has changed by -$140.04M (-47.75%)